IXI

Ixico Plc

20.00
0.50 (2.56%)
Share Name Share Symbol Market Type Share ISIN Share Description
Ixico Plc LSE:IXI London Ordinary Share GB00BFXR4C20 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 2.56% 20.00 12,212 12:24:12
Bid Price Offer Price High Price Low Price Open Price
19.00 21.00 20.00 19.50 19.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceutical Preparations 8.64 1.03 2.10 952.38 9.67
Last Trade Time Trade Type Trade Size Trade Price Currency
16:22:29 O 200 19.075 GBX

Ixico (IXI) Latest News

Ixico (IXI) Discussions and Chat

Ixico Forums and Chat

Date Time Title Posts
24/5/202303:13Ixico PLC347
28/4/202112:03IXICO324

Add a New Thread

Ixico (IXI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-05-31 15:22:3019.0820038.15O
2023-05-31 11:56:5220.201,000202.00O
2023-05-31 11:24:1321.00122.52O
2023-05-31 11:23:5019.7411,0002,171.40O

Ixico (IXI) Top Chat Posts

Top Posts
Posted at 10/5/2023 16:12 by halfpenny
IXI expected to exceed expectations as demand for its AI Product is huge.

Share price needs to get above 33p to reduce takeover target potential.

Great to add at these levels which wont stay at this level for long. As they say cheap as chips after the results today. Rapid rises in the pipeline. I say add if you can at these ridiculous levels.

Happy Days Ahead

Posted at 10/5/2023 08:29 by halfpenny
Now IXI have a strong platform with cash in the bank, AI products and a strong order book for 2023 and great outlook for 2024.

IXI with strong AI products being released puts them ahead of the market.

Investors now circulating IXI at these levels.

Future looking great for IXI.

Posted at 24/4/2023 12:45 by halfpenny
IXI now likely being pursued by a couple on investors who missed out on Medica Group Plc today.

Investors now circulating IXI at these levels. Only large deals with a share price above 33p can keep them away.

Future looking great for IXI.

Posted at 04/4/2023 15:15 by cliffpeat
@halfpenny

Can you tell us the source of your information regarding future orders/"great deals" and which of the income streams they relate to?

Do you have a steer on trials coming on line - or potential AI analytics demand - or the like?

And the price increases you refer to - are these related to what IXI charges customers or it the share price?

Posted at 04/4/2023 14:04 by halfpenny
I agree with more orders in the pipeline.

Maybe a Takeover still on the cards as IXICO price levels are attractive at the current levels.

IXI future is very bright so get ready for dramatic price increases ahead.

Following yesterday RNS Expect further RNS soon on great Deals. Get ready for a rapid rise as demand increases.

Also IXI are at Target takeover levels.

Posted at 04/4/2023 08:28 by halfpenny
Another Order for IXI so expect plenty more in the pipeline. Takeover target at these levels so needs rapid orders. Interesting times ahead so got more at these levels.

IXI have a huge increasing interest of its AI Products , is this when the company orders and sales pipeline grows quickly.

Maybe a Takeover still on the cards as IXICO price levels are attractive at the current levels.

IXI future is very bright so get ready for dramatic price increases ahead.

Following yesterday RNS Expect further RNS soon on great Deals.

Posted at 13/3/2023 06:49 by halfpenny
IXI have a huge increasing interest of its AI Products , is this when the company orders and sales pipeline grows quickly.

Maybe a Takeover still on the cards as IXICO price levels are attractive at the current levels.

IXI future is very bright so get ready for dramatic price increases ahead.

Expect further RNS soon on great Deals.

Posted at 24/2/2023 13:49 by halfpenny
IXI have a huge increasing interest of its AI Products , is this when the company orders and sales pipeline grows quickly.

Maybe a Takeover on the cards as IXICO price levels are attractive at the current levels.

IXI future is very bright so get ready for dramatic price increases ahead.

Expect RNS soon

Posted at 21/2/2023 23:39 by 40 fathoms
@halfpenny, I guess we have different views of what constitutes record breaking ! In my view the only record they are likely to break in the near term, is a record low share price.

Management are obscenely overpaid, the board is stale and out of its depth, the companies accounting policies are aggressive and they are at best 2 to 3 years from a meaningful recovery in revenue, they admit that themselves. In getting there they will exhaust almost all of their cash pile.

My view, without something very significant in the near term this will trade in the teens and get bought out at or below the current shareprice.

Posted at 21/4/2022 07:33 by tomboyb
IXICO plc New Contract Win
21/04/2022 7:00am
UK Regulatory (RNS & others)

Ixico (LSE:IXI)
Intraday Stock Chart

Thursday 21 April 2022

Click Here for more Ixico Charts.
TIDMIXI

RNS Number : 8126I

IXICO plc

21 April 2022

21 April 2022

IXICO plc

("IXICO" or the "Company")

Contract award with a new client for a Huntington's Disease ('HD') trial worth circa GBP800,000

IXICO plc (AIM: IXI), the neuroimaging Contract Research Organisation (CRO) delivering advanced AI analytical insights in neuroscience, is pleased to announce it has been selected by a new client to support its global prospective observational study to assess participants for the early detection of HD. HD is a rare, inherited disease that causes the progressive breakdown of nerve cells in the brain affecting movement, mood and thinking abilities.

The new client is a biotech company specialized in gene therapy for neurodegenerative and other genetic diseases. IXICO will provide a range of its imaging CRO and advanced analytics services across approximately 2.5 years.

Having combined AI imaging biomarker analysis across many HD trials, together with centralised CRO services, IXICO is continuously enhancing its validated disease-optimised advanced analytics technology for this indication. This new contract follows our recent presentation on our new deep learning-based platform, IXIQ.Ai, at the Annual HD Therapeutics Conference in Palm Springs, a technology which IXICO will be applying to this trial. This, together with the ability to deliver its services through our proprietary TrialTracker imaging data management platform, makes IXICO the clear partner of choice for this study.

Giulio Cerroni, Chief Executive Officer of IXICO, commented : " With no current cure for Huntington's, nor interventions that slow disease progression, HD is a devastating rare neurological condition with significant unmet medical needs. We are delighted to further extend our client base and support identifying new insights into this challenging rare neurodegenerative disease. We are committed to ensuring that our validated machine learning AI data analytics, combined with the quality assurance of our TrialTracker platform, enable clients to unlock new insights into disease progression and drug development."

For further information please contact:

Ixico share price data is direct from the London Stock Exchange
Your Recent History
LSE
IXI
Ixico
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230601 02:16:42